The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To investigate improvement in nocturia and nocturnal polyuria in nocturnal polyuria patients after silodosin administration by using a 3-day frequency volume chart. Methods: This was a prospective multicenter study. We enrolled nocturnal polyuria patients (nocturnal polyuria index [NPi] >0.33), aged ≥60 years, diagnosed with the 3-day frequency volume charts of patients with benign prostatic hyperplasia taking α-blockers. Of the 54 patients, 30 (55.6%) completed the study according to the study protocol (per-protocol group), and 24 dropped out (dropout group). Results: Of the 24 patients in the dropout group, 5 withdrew consent due to side effects or lack of efficacy, 7 were lost to follow- up at 4 weeks, 8 were lost to follow-up at 12 weeks, and 4 dropped out due to failure to complete 3-day frequency volume charts at 12 weeks. In the per-protocol group, there was significant improvement in the International Prostate Symptom Score (IPSS), especially question numbers 1, 3, 4, 5, 6, 7, and the quality of life question (P=0.001, P=0.007, P<0.001, P=0.003, P=0.049, P<0.001, and P<0.001, respectively). The Leeds sleep evaluation questionnaire (LSEQ) score for the sleep question improved from 64.36 to 70.43 (P=0.039). The NPi reduced from 0.4005 to 0.3573 (P=0.027); however, in many cases, there was no improvement in nocturnal polyuria itself. In intention-to-treat analysis, there were significant improvements in IPSS and LSEQ in 45 patients. Conclusions: In elderly nocturnal polyuria patients, silodosin monotherapy exhibits good efficacy in improving nocturia and nocturnal polyuria; however, the mean NPi was still >0.33. Considering the high dropout rate of our study due to no implementation of 3-day frequency volume charts, prospective and large-scale studies are needed to confirm our results.
Abstract
Purpose: To investigate improvement in nocturia and nocturnal polyuria in nocturnal polyuria patients after silodosin administration by using a 3-day frequency volume chart. Methods: This was a prospective multicenter study. We enrolled nocturnal polyuria patients (nocturnal polyuria index [NPi] >0.33), aged ≥60 years, diagnosed with the 3-day frequency volume charts of patients with benign prostatic hyperplasia taking α-blockers. Of the 54 patients, 30 (55.6%) completed the study according to the study protocol (per-protocol group), and 24 dropped out (dropout group). Results: Of the 24 patients in the dropout group, 5 withdrew consent due to side effects or lack of efficacy, 7 were lost to follow- up at 4 weeks, 8 were lost to follow-up at 12 weeks, and 4 dropped out due to failure to complete 3-day frequency volume charts at 12 weeks. In the per-protocol group, there was significant improvement in the International Prostate Symptom Score (IPSS), especially question numbers 1, 3, 4, 5, 6, 7, and the quality of life question (P=0.001, P=0.007, P<0.001, P=0.003, P=0.049, P<0.001, and P<0.001, respectively). The Leeds sleep evaluation questionnaire (LSEQ) score for the sleep question improved from 64.36 to 70.43 (P=0.039). The NPi reduced from 0.4005 to 0.3573 (P=0.027); however, in many cases, there was no improvement in nocturnal polyuria itself. In intention-to-treat analysis, there were significant improvements in IPSS and LSEQ in 45 patients. Conclusions: In elderly nocturnal polyuria patients, silodosin monotherapy exhibits good efficacy in improving nocturia and nocturnal polyuria; however, the mean NPi was still >0.33. Considering the high dropout rate of our study due to no implementation of 3-day frequency volume charts, prospective and large-scale studies are needed to confirm our results.
참고문헌 (24)
- Chang SC, "Multifactorial nature of male nocturia", Urology, 67, pp.541~544 (2006)
- Cornu JN, "A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management: a systematic review and meta-analysis", Eur Urol, 62, pp.877~890 (2012)
- Van Dijk MM, "The role of nocturia in the quality of life of men with lower urinary tract symptoms", BJU Int, 105, pp.1141~1146 (2010)
- Asplund R, "Nocturia, nocturnal polyuria, and sleep quality in the elderly", J Psychosom Res, 56, pp.517~525 (2004)
- Middelkoop HA, "Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep", J Gerontol A Biol Sci Med Sci, 51, pp.M108~M115 (1996)
- 김태헌, "The Prevalence of Lower Urinary Tract Symptoms in Korean Men Aged 40 Years or Older: A Population-Based Survey", International Neurourology Journal, 18(3), pp.126~132 (2014), 대한배뇨장애요실금학회
- Asplund R, "Health of the elderly with regard to sleep and nocturnal micturition", Scand J Prim Health Care, 10, pp.98~104 (1992)
- Wang CJ, "Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study", J Urol, 185, pp.219~223 (2011)
- Delfanian K, "DDAVP-associated hyponatremia", S D J Med, 54, pp.255~256 (2001)
- Kojima Y, "Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart", Neurourol Urodyn, 31, pp.80~85 (2012)
- Yoshida M, "Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms", benign prostatic hyperplasia, 2010, pp.29, 1276~1281
- Chapple CR, "Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placeboand active-controlled clinical trial performed in Europe", Eur Urol, 59, pp.342~352 (2011)
- Eisenhardt A, "Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies", World J Urol, 32, pp.1119~1125 (2014)
- Takao T, "Improvement of nocturia and sleep disturbance by silodosin in male patients with lower urinary tract symptoms", Int J Urol, 22, pp.236~238 (2015)
- van Kerrebroeck P, "The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.179~183 (2002)
- Tarrasch R, "Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients", Hum Psychopharmacol, 18, pp.603~610 (2003)
- Weiss JP, "Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study", J Urol, 190, pp.965~972 (2013)
- Montorsi F, "Diagnosis of BPH and treatment of LUTS among GPs: a European survey", Int J Clin Pract, 67, pp.114~119 (2013)
- van Kerrebroeck P, "Desmopressin in the treatment of nocturia: a doubleblind, placebo-controlled study", Eur Urol, 52, pp.221~229 (2007)
- Yoshimura K, "Nocturia and benign prostatic hyperplasia", Urology, 61, pp.786~790 (2003)
- Thomas S, "Some effects of changes of posture on water and electrolyte excretion by the human kidney", J Physiol, 139, pp.337~352 (1957)
- Gulur DM, "Nocturia as a manifestation of systemic disease", BJU Int, 107, pp.702~713 (2011)
- Abul-Fotouh Abdel-Maguid Ahmed, "Efficacy of an Enuresis Alarm, Desmopressin, and Combination Therapy in the Treatment of Saudi Children With Primary Monosymptomatic Nocturnal Enuresis", Investigative and Clinical Urology, 54(11), pp.783~790 (2013), 대한비뇨기과학회
- Takahashi S, "Clinical efficacy of an alpha1A", D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia, 2006, pp.13, 15~20